Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline genetic alterations in homologous recombination deficiency/DNA damage response genes in breast cancer
    Meeting Abstract

    Keske, A.; Terraf, P.; Gazzo, A.; Repetto, M.; Schwartz, C.; Ross, D.; Zhang, H.; Chandarlapaty, S.; Wen, H.; Brogi, E.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Genomic profiling of primary and metastatic malignant phyllodes tumors
    Meeting Abstract

    Yildirim, S. Y.; Selenica, P.; Gazzo, A.; Ross, D.; Brogi, E.; Weigelt, B.; Pareja, F.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Evaluation of specific histopathologic parameters and myometrial invasion patterns in stage I endometrial carcinoma
    Meeting Abstract

    Akinyemi, A.; Ellenson, L.; Boroujeni, A. M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Immunohistochemical staining for RAS Q61R mutation in B-cell lymphoproliferative disorders identifies mutated subclones
    Meeting Abstract

    Isgor, I.; Liu, Y.; Lopez, K.; Jungbluth, A.; Serrette, R.; Dogan, A.; Chan, A.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • ERBB2 amplification occurs late in the pathogenesis of high-grade endometrial carcinomas with HER2 expression heterogeneity
    Meeting Abstract

    Chui, M. H.; Brown, D.; Ellenson, L.; Weigelt, B.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Robotic resection of spinal and paraspinal tumors
    Journal Article

    Barzilai, O.; Goh, A. C.; Park, B.; Rusch, V.; Weiser, M.; Leitao, M. M. Jr; Reiner, A. S.; Newman, W. C.; Bilsky, M. H.
    Operative Neurosurgery (2025)

    Fulltext@MSK | Save
  • Novel combination of immunotherapy and tyrosine kinase inhibitor for recurrent cervical cancer: Balancing efficacy and toxicity
    Editorial

    Perez, S. S. M.; O'Cearbhaill, R. E.
    Gynecology and Pelvic Medicine (2025)

    Fulltext@MSK | Save
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma
    Journal Article

    Dagher, C.; Bjerre Trent, P.; Alwaqfi, R.; Davidson, B.; Ellenson, L. H.; Zhou, Q.; Iasonos, A.; Mueller, J. J.; Alektiar, K.; Makker, V.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Summary of research: Efficacy of trastuzumab deruxtecan in HER2-expressing solid tumors by enrollment HER2 IHC status: Post hoc analysis of DESTINY-PanTumor02
    Journal Article

    Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Banerjee, S.; González-Martín, A.; Jung, K. H.; Ługowska, I.; Manso, L.; Manzano, A.; more...
    Advances in Therapy (2025)

    Fulltext@MSK | Save